Effectiveness of a Knowledge-based Intervention for Patients With Cutaneous Lupus Erythematosus - Trial NCT01629784
Access comprehensive clinical trial information for NCT01629784 through Pure Global AI's free database. This phase not specified trial is sponsored by Northwestern University and is currently Completed. The study focuses on Cutaneous Lupus Erythematosus. Target enrollment is 31 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Northwestern University
Timeline & Enrollment
N/A
May 01, 2012
Jan 01, 2013
Primary Outcome
Percentage of Subjects Who Correctly Answered a Knowledge Assessment Item Immediately Before and After an Educational Lecture
Summary
Studies have shown that there are significant differences in severity and outcome of lupus in
 patients of colored skin compared with Caucasians. There are many factors that lead to this
 discrepancy: genetics, poverty, education level, as well as behavioral and cultural factors.
 Cutaneous Lupus Erythematosus (CLE) is a disease of flares and remissions with identifiable
 triggers. One of the most aggravating triggers in CLE is sun exposure. The investigators
 hypothesize that there are disparities in knowledge about photoprotection, leading to poorer
 outcomes in minority ethnic groups. This study aims to assess knowledge of risk factors and
 triggers, especially sun exposure, and the effects on quality of life of Caucasian and
 minority populations, by conducting an assessment survey and subsequent teaching intervention
 on appropriate skin protection techniques including appropriate sun screen application, and
 use of sun-protective clothing. After three months a survey to evaluate knowledge retention
 about and the application of the educational intervention will be conducted.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT01629784
Non-Device Trial